Breaking News, Financial News

Financial Reports: AMRI 2Q11

Discovery services down, but other businesses on the rise.

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

AMRI 2Q11 2Q Revenues: $53.9 million (+9%) 2Q Loss: $0.6 million (loss of $3.9 million in 2Q10) YTD Revenues: $110.8 million (+12%) YTD Earnings: $2.0 million (loss of $3.9 million in 2Q10) Comments: Contract Revenues rose overall 7% in 2Q10, but Discovery Services were down 25% to $8.9 million during that time. Development/Small Scale Manufacturing revenues grew 18% to $9.1 million and Large Scale Manufacturing was up 21% to $25.5 million. For the first half of the year, contract revenues ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters